Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 2000 |
100 Clinical Results associated with Nanjing Xiaoying Pharmaceutical Factory
0 Patents (Medical) associated with Nanjing Xiaoying Pharmaceutical Factory
100 Deals associated with Nanjing Xiaoying Pharmaceutical Factory
100 Translational Medicine associated with Nanjing Xiaoying Pharmaceutical Factory